More interestingly, we found a greater release of IL-2 and GrB co-cultured with tumor-infiltrating CD3+CD8+ T cells than that co-cultured with tumor-infiltrating CD3+ T cells at the treatment with RCE plus Oxa. The gene discussed is GZMB; the disease is neoplasm.